Advances in Metabolism and Metabolic Toxicology of Quinoxaline 1,4-Di-N-oxides

Chem Res Toxicol. 2024 Apr 15;37(4):528-539. doi: 10.1021/acs.chemrestox.4c00019. Epub 2024 Mar 20.

Abstract

Quinoxaline 1,4-di-N-Oxides (QdNOs) have been used as synthetic antimicrobial agents in animal husbandry and aquaculture. The metabolism and potential toxicity have been also concerns in recently years. The metabolism investigations showed that there were 8 metabolites of Carbadox (CBX), 34 metabolites of Cyadox (CYA), 33 metabolites of Mequindox (MEQ), 35 metabolites of Olaquindox (OLA), and 56 metabolites of Quinocetone (QCT) in different animals. Among them, Cb3 and Cb8, M6, and O9 are metabolic residual markers of CBX, MEQ and OLA, which are associated with N → O reduction. Toxicity studies revealed that QdNOs exhibited severe tumorigenicity, cytotoxicity, and adrenal toxicity. Metabolic toxicology showed that toxicity of QdNOs metabolites might be related to the N → O group reduction, and some metabolites exhibited higher toxic effects than the precursor, which could provide guidance for further research on the metabolic toxicology of QdNOs and provide a wealth of information for food safety evaluation.

Publication types

  • Review

MeSH terms

  • Animals
  • Carbadox
  • Oxidative Stress
  • Oxides*
  • Quinoxalines* / metabolism
  • Quinoxalines* / toxicity

Substances

  • quindoxin
  • Oxides
  • Quinoxalines
  • Carbadox